Stock Quote
Stock Chart
Minimum 15 minutes delayed. Source: LSEG
| Date Requested | Open Price | Day High | Day Low | Closing Price | Volume | Split Adjustment Factor |
|---|---|---|---|---|---|---|
| June 22, 2026 | $329.55 | $329.86 | $324.68 | $329.71 | 842,928 | 1:1 |
| June 23, 2026 | $328.45 | $336.50 | $327.61 | $336.39 | 784,658 | 1:1 |
| June 24, 2026 | $335.72 | $345.99 | $335.72 | $340.41 | 872,611 | 1:1 |
| June 25, 2026 | $345.00 | $352.31 | $345.00 | $346.56 | 1,615,321 | 1:1 |
| June 26, 2026 | $345.36 | $351.35 | $342.70 | $350.85 | 1,254,978 | 1:1 |
NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. The closing price is not necessarily indicative of future price performance.
Minimum 15 minutes delayed. Source: LSEG
Return calculations do not include reinvested cash dividends.
Minimum 15 minutes delayed. Source: LSEG
| Firm | Analyst |
|---|---|
|
Barclays
|
Luke Sergott |
|
BofA Global Research
|
Michael Ryskin |
|
Citibank
|
Patrick Donnelley |
|
CJS Securities
|
Lawrence Solow |
|
Cowen
|
Brendan Smith |
|
Deutsche Bank
|
Justin Bowers |
|
Evercore
|
Daniel Markowitz |
|
Jefferies
|
David Windley |
|
KeyBanc Capital Markets Inc.
|
Paul Knight |
|
Morgan Stanley
|
Kallum Titchmarsh |
|
Morningstar, Inc.
|
Jay Lee |
|
Rothchild Redburn
|
Jamie Clark |
|
Stephens Inc.
|
Mac Etoch |
|
William Blair & Company
|
Matthew Larew |
|
Wolfe
|
Mike Polark |
West Pharmaceutical Services, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding West Pharmaceutical Services, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of West Pharmaceutical Services, Inc. or its management. West Pharmaceutical Services, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.